Medical Ethics and Law Flashcards

A pharmacist discovers that a colleague has been dispensing opioids to a patient without a valid prescription by backdating refill records. The colleague is also the pharmacist-in-charge and threatens the pharmacist with termination if reported. Under Canadian pharmacy law and professional obligations, what is the pharmacist's PRIMARY duty?

Answer: Report the conduct to the provincial regulatory college, regardless of employment consequences

Canadian pharmacy regulatory frameworks (provincial Pharmacy Acts and codes of ethics) impose a mandatory duty to report professional misconduct that poses a risk to patient safety. The threat of employment consequences does not override this professional and, in most provinces, legal obligation. Backdating records to dispense opioids without a valid prescription constitutes both professional misconduct and a criminal offence under the Controlled Drugs and Substances Act. Reporting to the regulatory college is the primary duty; it may also involve law enforcement, but the college is the appropriate first step for a professional conduct matter.

A competent adult patient with end-stage renal disease explicitly refuses dialysis and states she wants to proceed with MAID (Medical Assistance in Dying). The patient asks the pharmacist to explain the medications involved. The pharmacist has a sincere conscientious objection to MAID. Which of the following represents the pharmacist's correct ethical and legal obligation under Canadian federal law (Bill C-14/C-7) and most provincial college standards?

Answer: Provide the patient with an effective referral to another pharmacist or pharmacy able to assist, without impeding access

Under Canada's MAID legislation and provincial college guidelines (e.g., OCP, NAPRA model standards), pharmacists who conscientiously object to MAID are not required to directly participate, but they retain a professional duty to ensure the patient is not abandoned — this means providing a timely and effective referral. Simply refusing without referral is a violation of professional standards. Dispensing against one's conscience is not mandated. The two-physician confirmation is a clinical/legislative requirement for the MAID process itself, not a pharmacist gatekeeping role.

A pharmacist receives a prescription for warfarin with a potentially lethal drug interaction with a newly added medication in the patient's profile. The patient is incapacitated (post-surgical sedation) and unavailable for counselling. The prescribing physician is unreachable. The patient's adult child, who has no documented power of attorney for personal care, is present and insists the pharmacist dispense immediately as the patient 'would want it.' What is the most ethically and legally defensible course of action?

Answer: Withhold dispensing and escalate urgently through the hospital chain of command or on-call physician to resolve the interaction before dispensing

An undocumented family member without legal authority (power of attorney for personal care) cannot provide substitute consent for medication decisions in Canadian healthcare law. The pharmacist's professional duty to prevent harm (non-maleficence) requires withholding a potentially lethal interaction until a qualified prescriber can authorize or address it. Escalating through the hospital chain of command (charge nurse, on-call physician, or department head) is the correct institutional mechanism. Dispensing based on the child's request or a liability waiver would expose the pharmacist to professional and legal liability.

Under the Personal Information Protection and Electronic Documents Act (PIPEDA) and provincial equivalents, a pharmacist receives a court subpoena requesting a patient's full dispensing history for the past 5 years in a civil lawsuit where the patient is NOT a party. The patient has not consented. Which statement best describes the pharmacist's obligations?

Answer: The pharmacist must comply with a valid court order but should disclose only the minimum information specified and may notify the patient beforehand if legally permitted

PIPEDA and provincial privacy legislation recognize court orders as a lawful authority exception to consent requirements. However, 'lawful authority' does not mean unlimited or unrestricted disclosure — pharmacists should disclose the minimum necessary information, verify the subpoena's scope, and consult legal counsel. Where legally permissible (and not prohibited by the court order itself), notifying the patient allows them to seek a motion to quash or limit the subpoena. Destroying records in response to a subpoena constitutes obstruction of justice. Absolute refusal based on PIPEDA alone, ignoring a court order, is also incorrect.

A pharmacist in a remote First Nations community learns that a local traditional healer has been advising community members to discontinue insulin therapy in favour of a traditional herbal regimen for Type 2 diabetes. Several patients have presented with elevated blood glucose levels. Applying the ethical principles of cultural competency and non-maleficence within the Canadian healthcare context, what is the most appropriate pharmacist response?

Answer: Engage respectfully with both patients and, where possible, the healer to provide evidence-based risk information, support informed decision-making, and collaborate rather than dismiss traditional practices

The Canadian healthcare framework, including the TRC Calls to Action and NAPRA guidelines, emphasizes cultural safety and respectful engagement with Indigenous health practices. A pharmacist's duty of non-maleficence requires addressing the insulin discontinuation risk, but this must be balanced with patient autonomy and cultural respect. Collaborative dialogue — explaining specific pharmacological risks while acknowledging traditional practices — is both ethically and practically superior. Immediately reporting the healer is disproportionate and potentially harmful to community trust. Dispensing insulin that a patient has stated they will not use does not address the clinical risk and may waste resources.

A pharmaceutical company invites a pharmacist to be a paid 'advisory board member' at $2,000 per meeting to provide feedback on a drug the pharmacist currently recommends frequently to patients. The pharmacist does not disclose this arrangement to patients or on provincial conflict-of-interest declarations. Under Canadian pharmacy ethics standards, which of the following is MOST accurate regarding this situation?

Answer: This constitutes an undisclosed conflict of interest that must be declared to the provincial college and, where relevant, to patients, regardless of whether it influences prescribing behaviour

NAPRA's Model Standards of Practice and all provincial codes of ethics require pharmacists to identify, disclose, and manage conflicts of interest — including financial relationships with pharmaceutical manufacturers. The obligation exists regardless of whether the conflict actually influences behaviour, because undisclosed conflicts undermine patient trust and professional integrity. Provincial colleges typically require declaration on annual renewal forms and may require disclosure in clinical contexts. The argument that 'advice is legitimate' does not eliminate the disclosure obligation. The conflict-of-interest rules apply to all licensed pharmacists, not only owners.